Sharing Circulating Micro-RNAs between Osteoporosis and Sarcopenia: A Systematic Review.
microRNA
osteoporosis
osteosarcopenia
sarcopenia
systematic review
Journal
Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444
Informations de publication
Date de publication:
21 Feb 2023
21 Feb 2023
Historique:
received:
30
01
2023
revised:
13
02
2023
accepted:
14
02
2023
medline:
30
3
2023
entrez:
29
3
2023
pubmed:
30
3
2023
Statut:
epublish
Résumé
Osteosarcopenia, a combination of osteopenia/osteoporosis and sarcopenia, is a common condition among older adults. While numerous studies and meta-analyses have been conducted on osteoporosis biomarkers, biomarker utility in osteosarcopenia still lacks evidence. Here, we carried out a systematic review to explore and analyze the potential clinical of circulating microRNAs (miRs) shared between osteoporosis/osteopenia and sarcopenia. We performed a systematic review on PubMed, Scopus, and Embase for differentially expressed miRs ( A total of 69 miRs were identified for osteoporosis and 14 for sarcopenia. There were 9 shared miRs, with evidence of dysregulation (up- or down-regulation), in both osteoporosis and sarcopenia: miR-23a-3p, miR-29a, miR-93, miR-133a and b, miR-155, miR-206, miR-208, miR-222, and miR-328, with functions and targets implicated in the pathogenesis of osteosarcopenia. However, there was little agreement in the results across studies and insufficient data for miRs in sarcopenia, and only three miRs, miR-155, miR-206, and miR-328, showed the same direction of dysregulation (down-regulation) in both osteoporosis and sarcopenia. Additionally, for most identified miRs there has been no replication by more than one study, and this is particularly true for all miRs analyzed in sarcopenia. The study quality was typically rated intermediate/high risk of bias. The large heterogeneity of the studies made it impossible to perform a meta-analysis. The findings of this review are particularly novel, as miRs have not yet been explored in the context of osteosarcopenia. The dysregulation of miRs identified in this review may provide important clues to better understand the pathogenesis of osteosarcopenia, while also laying the foundations for further studies to lead to effective screening, monitoring, or treatment strategies.
Sections du résumé
BACKGROUND
BACKGROUND
Osteosarcopenia, a combination of osteopenia/osteoporosis and sarcopenia, is a common condition among older adults. While numerous studies and meta-analyses have been conducted on osteoporosis biomarkers, biomarker utility in osteosarcopenia still lacks evidence. Here, we carried out a systematic review to explore and analyze the potential clinical of circulating microRNAs (miRs) shared between osteoporosis/osteopenia and sarcopenia.
METHODS
METHODS
We performed a systematic review on PubMed, Scopus, and Embase for differentially expressed miRs (
RESULTS
RESULTS
A total of 69 miRs were identified for osteoporosis and 14 for sarcopenia. There were 9 shared miRs, with evidence of dysregulation (up- or down-regulation), in both osteoporosis and sarcopenia: miR-23a-3p, miR-29a, miR-93, miR-133a and b, miR-155, miR-206, miR-208, miR-222, and miR-328, with functions and targets implicated in the pathogenesis of osteosarcopenia. However, there was little agreement in the results across studies and insufficient data for miRs in sarcopenia, and only three miRs, miR-155, miR-206, and miR-328, showed the same direction of dysregulation (down-regulation) in both osteoporosis and sarcopenia. Additionally, for most identified miRs there has been no replication by more than one study, and this is particularly true for all miRs analyzed in sarcopenia. The study quality was typically rated intermediate/high risk of bias. The large heterogeneity of the studies made it impossible to perform a meta-analysis.
CONCLUSIONS
CONCLUSIONS
The findings of this review are particularly novel, as miRs have not yet been explored in the context of osteosarcopenia. The dysregulation of miRs identified in this review may provide important clues to better understand the pathogenesis of osteosarcopenia, while also laying the foundations for further studies to lead to effective screening, monitoring, or treatment strategies.
Identifiants
pubmed: 36983758
pii: life13030602
doi: 10.3390/life13030602
pmc: PMC10051676
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Progetto PCR2022 - PROGETTO RETE AGING - PIANO ESECUTIVO 2022
ID : D33C22001520001
Références
Ann Intern Med. 2011 Oct 18;155(8):529-36
pubmed: 22007046
Biomed Pharmacother. 2019 Aug;116:108960
pubmed: 31112871
J Bone Miner Res. 2014 Aug;29(8):1718-28
pubmed: 24431276
Maturitas. 2019 Jan;119:61-69
pubmed: 30502752
Calcif Tissue Int. 2015 Nov;97(5):495-505
pubmed: 26163235
Anat Rec A Discov Mol Cell Evol Biol. 2003 Dec;275(2):1081-101
pubmed: 14613308
Biomed Res Int. 2020 Jul 30;2020:5047243
pubmed: 32802851
J Musculoskelet Neuronal Interact. 2021 Jun 1;21(2):298-307
pubmed: 34059575
Bone. 2015 Oct;79:43-51
pubmed: 26026730
Am J Physiol Cell Physiol. 2019 Jan 1;316(1):C57-C69
pubmed: 30379578
Obes Res Clin Pract. 2017 Mar - Apr;11(2):177-187
pubmed: 27133528
Cell Mol Life Sci. 2019 Oct;76(19):3723-3744
pubmed: 31147752
Mol Cell Probes. 2020 Feb;49:101479
pubmed: 31706013
J Am Geriatr Soc. 2020 Jul;68(7):1410-1418
pubmed: 32150289
J Am Geriatr Soc. 2002 May;50(5):889-96
pubmed: 12028177
Cell Death Dis. 2016 Jun 09;7(6):e2261
pubmed: 27277683
Hepatology. 2011 Jan;53(1):209-18
pubmed: 20890893
Eurasian J Med. 2011 Aug;43(2):109-14
pubmed: 25610174
J Cell Sci. 2012 Aug 1;125(Pt 15):3590-600
pubmed: 22595520
BMC Musculoskelet Disord. 2022 Aug 17;23(1):789
pubmed: 35978328
J Bone Miner Res. 1997 Oct;12(10):1539-46
pubmed: 9333113
PLoS One. 2008 Sep 05;3(9):e3148
pubmed: 18773077
Front Endocrinol (Lausanne). 2020 Oct 21;11:516213
pubmed: 33193074
Wien Klin Wochenschr. 2016 Dec;128(Suppl 7):519-526
pubmed: 27900532
Cell Metab. 2010 Oct 6;12(4):341-351
pubmed: 20727829
Arthritis Rheum. 2010 Jun;62(6):1733-43
pubmed: 20201077
Eur Rev Med Pharmacol Sci. 2019 Oct;23(20):8721-8729
pubmed: 31696458
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Eur Rev Med Pharmacol Sci. 2020 Jan;24(2):526-534
pubmed: 32016954
Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):7766-7774
pubmed: 31599402
Injury. 2022 Nov;53(11):3636-3641
pubmed: 36070969
Bone. 2020 Jan;130:115105
pubmed: 31669252
PLoS One. 2021 Apr 26;16(4):e0250717
pubmed: 33901236
Mol Ther Nucleic Acids. 2020 Sep 4;21:814-823
pubmed: 32791453
Sci Rep. 2021 Sep 29;11(1):19372
pubmed: 34588560
BMC Musculoskelet Disord. 2020 Jul 13;21(1):456
pubmed: 32660465
Biochem Biophys Res Commun. 2019 Aug 27;516(3):666-672
pubmed: 31248594
Bioengineered. 2021 Dec;12(1):7714-7723
pubmed: 34617877
Front Cell Dev Biol. 2022 Dec 13;10:1092776
pubmed: 36582467
Physiol Res. 2021 Nov 30;70(Suppl 1):S91-S98
pubmed: 35503054
J Clin Med. 2021 Jun 12;10(12):
pubmed: 34204622
Eur Rev Med Pharmacol Sci. 2019 Aug;23(3 Suppl):73-80
pubmed: 31389577
Front Endocrinol (Lausanne). 2022 May 13;13:864299
pubmed: 35634507
J Bone Metab. 2014 Feb;21(1):29-40
pubmed: 24707465
Ther Adv Musculoskelet Dis. 2020 Sep 24;12:1759720X20953331
pubmed: 33029202
Eur Rev Med Pharmacol Sci. 2018 Aug;22(16):5098-5105
pubmed: 30178828
Nutr Healthy Aging. 2017 Dec 7;4(3):227-237
pubmed: 29276792
Mol Med Rep. 2019 Jul;20(1):270-280
pubmed: 31115543
Dis Markers. 2021 Dec 13;2021:3719919
pubmed: 34938374
Arch Biochem Biophys. 2014 Dec 15;564:173-83
pubmed: 25241053
Eur J Endocrinol. 2017 Feb;176(2):169-176
pubmed: 27836951
Cell Physiol Biochem. 2016;39(1):253-65
pubmed: 27337099
Int J Mol Sci. 2020 Jul 10;21(14):
pubmed: 32664424
Genet Res (Camb). 2022 Mar 7;2022:3838126
pubmed: 35321519
Biochem Cell Biol. 2018 Oct;96(5):627-635
pubmed: 29334613
Acta Biochim Biophys Sin (Shanghai). 2018 Mar 1;50(3):273-280
pubmed: 29425279
J Bone Miner Res. 2012 Jul;27(7):1598-606
pubmed: 22467200
J Clin Endocrinol Metab. 2022 Jul 14;107(8):2267-2285
pubmed: 35532548
J Endocrinol Invest. 2019 Oct;42(10):1149-1164
pubmed: 30980341
Bone. 2019 Mar;120:271-278
pubmed: 30408612
J Cell Biol. 2006 Aug 28;174(5):677-87
pubmed: 16923828
Nat Rev Genet. 2004 Jul;5(7):522-31
pubmed: 15211354
Bone. 2012 Sep;51(3):498-505
pubmed: 22634176
J Back Musculoskelet Rehabil. 2018 Feb 6;31(1):211-214
pubmed: 28854498
Am J Respir Cell Mol Biol. 2011 Aug;45(2):287-94
pubmed: 20971881
J Bone Miner Res. 2020 Feb;35(2):306-316
pubmed: 31614022
RNA Biol. 2014;11(11):1355-63
pubmed: 25692234
Maturitas. 2016 Nov;93:13-17
pubmed: 27131919
Front Genet. 2020 Mar 05;11:167
pubmed: 32194634
J Am Med Dir Assoc. 2015 Apr;16(4):290-5
pubmed: 25512216
Mol Cell Endocrinol. 2016 Sep 5;432:83-95
pubmed: 26525415
Gene. 2018 Dec 30;679:19-27
pubmed: 30171938
Eur J Med Res. 2021 Jan 18;26(1):8
pubmed: 33461610
Clin Lab. 2019 Sep 1;65(9):
pubmed: 31532098
Sci Rep. 2016 Nov 08;6:36347
pubmed: 27821865
Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):949-957
pubmed: 30779060
Steroids. 2022 Sep;185:109063
pubmed: 35700796
Cell Res. 2008 Oct;18(10):997-1006
pubmed: 18766170
BMC Geriatr. 2021 Jan 30;21(1):86
pubmed: 33516190
Eur Rev Med Pharmacol Sci. 2018 Sep;22(18):5804-5814
pubmed: 30280759
Eur Rev Med Pharmacol Sci. 2019 Aug;23(16):6791-6799
pubmed: 31486477
J Orthop Sci. 2016 Nov;21(6):852-858
pubmed: 27545451
Bone. 2019 May;122:52-75
pubmed: 30772601
Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13027-32
pubmed: 18723672
Cell Death Dis. 2016 Feb 04;7:e2086
pubmed: 26844700
Mol Med Rep. 2021 Oct;24(4):
pubmed: 34396445
Sci Rep. 2018 May 30;8(1):8421
pubmed: 29849050
J Bone Miner Res. 2019 Jun;34(6):1074-1085
pubmed: 30830972
J Musculoskelet Neuronal Interact. 2021 Jun 1;21(2):308-316
pubmed: 34059576
J Bone Miner Res. 2012 Jul;27(7):1480-6
pubmed: 22431426
Arch Biochem Biophys. 2020 May 15;684:108331
pubmed: 32151564
Int J Endocrinol. 2015;2015:482940
pubmed: 26273298
Exp Ther Med. 2019 Jan;17(1):709-714
pubmed: 30651854
Biomarkers. 2014 Nov;19(7):553-6
pubmed: 25231354
J Aging Res. 2020 Apr 24;2020:3431828
pubmed: 32377434
J Int Med Res. 2020 Jul;48(7):300060520926353
pubmed: 32720595
Front Physiol. 2021 Jun 07;12:678610
pubmed: 34163374
J Clin Endocrinol Metab. 2020 May 1;105(5):
pubmed: 31872255
Biomed Res Int. 2015;2015:676575
pubmed: 26258142
RNA Biol. 2020 May;17(5):743-754
pubmed: 32037961